24×7 Online Assistance Email info@medicalthesistopic.in WhatsApp support Hours 08:00 – 21:00 IST
MD · Para-clinical

Pharmacology MD Thesis Topics — 60+ titles

Updated September 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 60+ MD Pharmacology dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Click any title to get the objective on WhatsApp — instant, free, no signup.

60+MD Pharmacology titles
24×7WhatsApp objective delivery
100%Plagiarism-free, IEC-ready

MD Pharmacology — Thesis Title List

60 titles · objectives via WhatsApp
  1. 001

    Drug utilisation pattern of antihypertensive agents in patients attending the medicine outpatient department of a tertiary care hospital using WHO core prescribing indicators

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  2. 002

    Prescription pattern and adherence to standard treatment guidelines in the management of type 2 diabetes mellitus

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  3. 003

    Antimicrobial prescribing pattern in the intensive care unit using WHO AWaRe classification and defined daily dose

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  4. 004

    Drug utilisation study of antiepileptic drugs in the neurology outpatient department with assessment of seizure control

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  5. 005

    Prescribing pattern of psychotropic drugs in patients with schizophrenia and bipolar disorder at a tertiary care psychiatry unit

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  6. 006

    Evaluation of prescriptions in the paediatric outpatient department for rationality, generic prescribing and adherence to essential medicines list

    Drug Utilisation Cross-sectional prescription audit Drug Utilisation Study
    Objective
  7. 007

    Drug utilisation and cost analysis of antimicrobials in surgical prophylaxis and adherence to hospital antibiotic policy

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  8. 008

    Pattern of drug use in pregnancy and assessment of FDA risk categories in antenatal outpatients

    Drug Utilisation Cross-sectional study Drug Utilisation Study
    Objective
  9. 009

    Prescribing pattern in geriatric patients and prevalence of potentially inappropriate medications using Beers criteria

    Drug Utilisation Cross-sectional study Drug Utilisation Study
    Objective
  10. 010

    Polypharmacy and potential drug-drug interactions in patients admitted to the medicine ward: a prospective analysis

    Drug Utilisation Prospective observational study Cross-sectional Study
    Objective
  11. 011

    Pattern, causality and severity of adverse drug reactions reported at an ADR monitoring centre of a tertiary care hospital

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  12. 012

    Adverse drug reactions to first-line anti-tubercular therapy under the NTEP and their impact on treatment adherence

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  13. 013

    Cutaneous adverse drug reactions: clinical pattern, causative drugs and causality assessment using WHO-UMC and Naranjo scales

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  14. 014

    Adverse drug reactions to cancer chemotherapy in the oncology day-care unit: pattern, severity and preventability

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  15. 015

    Knowledge, attitude and practice of adverse drug reaction reporting among resident doctors and nurses and effect of an educational intervention

    Adverse Drug Reactions Pre-post interventional study KAP Study
    Objective
  16. 016

    Adverse drug reactions to antiretroviral therapy and their association with treatment regimen and CD4 count

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  17. 017

    Adverse events following immunisation reported at a tertiary care hospital: pattern and causality assessment

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  18. 018

    Drug-induced hepatotoxicity in patients on anti-tubercular therapy: incidence, risk factors and outcome

    Adverse Drug Reactions Prospective observational study Prospective Study
    Objective
  19. 019

    Cost-effectiveness analysis of different oral antidiabetic regimens in type 2 diabetes mellitus at a tertiary care hospital

    Pharmacoeconomics Prospective observational study Pharmacoeconomic Study
    Objective
  20. 020

    Cost variation analysis of branded versus generic antihypertensive drugs available in the Indian market

    Pharmacoeconomics Cross-sectional cost analysis Pharmacoeconomic Study
    Objective
  21. 021

    Cost of illness analysis in patients with chronic kidney disease on maintenance haemodialysis

    Pharmacoeconomics Prospective observational study Pharmacoeconomic Study
    Objective
  22. 022

    Cost minimisation analysis of antimicrobial therapy in community-acquired pneumonia: intravenous versus early switch to oral

    Pharmacoeconomics Prospective observational study Pharmacoeconomic Study
    Objective
  23. 023

    Impact of Jan Aushadhi generic medicines on out-of-pocket expenditure in patients with chronic diseases

    Pharmacoeconomics Cross-sectional study Pharmacoeconomic Study
    Objective
  24. 024

    Therapeutic drug monitoring of phenytoin and valproate in patients with epilepsy and correlation with seizure control and toxicity

    Therapeutic Drug Monitoring Prospective observational study Prospective Study
    Objective
  25. 025

    Therapeutic drug monitoring of vancomycin trough levels in ICU patients and correlation with nephrotoxicity

    Therapeutic Drug Monitoring Prospective observational study Prospective Study
    Objective
  26. 026

    Serum lithium levels and their correlation with clinical response and adverse effects in patients with bipolar disorder

    Therapeutic Drug Monitoring Prospective observational study Prospective Study
    Objective
  27. 027

    Tacrolimus trough levels and their correlation with graft function and toxicity in renal transplant recipients

    Therapeutic Drug Monitoring Prospective observational study Prospective Study
    Objective
  28. 028

    Comparison of efficacy and safety of dapagliflozin versus sitagliptin as add-on therapy to metformin in type 2 diabetes mellitus

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  29. 029

    Comparative evaluation of telmisartan versus amlodipine on blood pressure control and metabolic parameters in stage 1 hypertension

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  30. 030

    Efficacy and safety of escitalopram versus sertraline in major depressive disorder: a randomised comparative study

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  31. 031

    Comparison of rosuvastatin versus atorvastatin on lipid profile and hs-CRP in patients with dyslipidaemia

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  32. 032

    Effect of vitamin D supplementation on glycaemic control in vitamin D deficient patients with type 2 diabetes mellitus

    Clinical Trials Randomised controlled trial Interventional Study
    Objective
  33. 033

    Efficacy of pregabalin versus duloxetine in painful diabetic peripheral neuropathy: a randomised comparative study

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  34. 034

    Comparison of pantoprazole versus rabeprazole in gastro-oesophageal reflux disease: symptom relief and quality of life

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  35. 035

    Efficacy and tolerability of metformin versus myo-inositol in women with polycystic ovary syndrome

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  36. 036

    Evaluation of the analgesic and anti-inflammatory activity of a medicinal plant extract in experimental animal models

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  37. 037

    Evaluation of the antidiabetic effect of a herbal extract in streptozotocin-induced diabetic rats

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  38. 038

    Hepatoprotective activity of a plant extract against paracetamol-induced hepatotoxicity in albino rats

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  39. 039

    Evaluation of the anxiolytic and antidepressant activity of a test compound in rodent behavioural models

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  40. 040

    Wound-healing activity of a topical herbal formulation in excision and incision wound models in rats

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  41. 041

    Evaluation of the anticonvulsant activity of a test drug in maximal electroshock and pentylenetetrazole-induced seizure models

    Experimental Pharmacology Experimental animal study Experimental Study
    Objective
  42. 042

    Prevalence of self-medication and its determinants among undergraduate medical students

    Rational Use & Behaviour Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  43. 043

    Medication adherence and its determinants in patients with hypertension using the Morisky scale

    Rational Use & Behaviour Cross-sectional study Cross-sectional Study
    Objective
  44. 044

    Knowledge, attitude and practice regarding antibiotic use and resistance among the general public attending a tertiary care hospital

    Rational Use & Behaviour Cross-sectional questionnaire-based study KAP Study
    Objective
  45. 045

    Assessment of fixed-dose combinations prescribed in outpatient departments for rationality and inclusion in the essential medicines list

    Rational Use & Behaviour Cross-sectional prescription audit Cross-sectional Study
    Objective
  46. 046

    Evaluation of drug information leaflets of commonly prescribed medicines for completeness and readability

    Rational Use & Behaviour Cross-sectional analytical study Cross-sectional Study
    Objective
  47. 047

    Impact of a pharmacist-led counselling intervention on medication adherence in patients with type 2 diabetes mellitus

    Rational Use & Behaviour Randomised controlled trial Interventional Study
    Objective
  48. 048

    Effect of CYP2C19 genotype on clinical response to clopidogrel in patients with acute coronary syndrome

    Pharmacogenomics Prospective observational study Prospective Study
    Objective
  49. 049

    Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirement in patients on oral anticoagulation

    Pharmacogenomics Cross-sectional study Cross-sectional Study
    Objective
  50. 050

    Antimicrobial resistance pattern of isolates in the ICU and correlation with antimicrobial consumption over three years

    Antimicrobial Stewardship Retrospective record-based study Cross-sectional Study
    Objective
  51. 051

    Impact of an antimicrobial stewardship programme on antibiotic consumption and cost in a tertiary care hospital

    Antimicrobial Stewardship Pre-post interventional study Quality Improvement Study
    Objective
  52. 052

    Prescription audit of antimicrobials in the emergency department against national treatment guidelines

    Antimicrobial Stewardship Prospective audit Audit
    Objective
  53. 053

    Evaluation of medication errors in the medicine ward and effect of an educational intervention on their frequency

    Medication Safety Pre-post interventional study Quality Improvement Study
    Objective
  54. 054

    Assessment of prescription writing errors in a tertiary care hospital and impact of a prescription-writing training module for interns

    Medication Safety Pre-post interventional study Educational Study
    Objective
  55. 055

    Comparison of the effectiveness of case-based learning versus didactic lectures in teaching pharmacology to second-year MBBS students

    Medical Education Randomised educational intervention Educational Study
    Objective
  56. 056

    Perception of medical students and faculty towards computer-assisted learning as an alternative to animal experiments in pharmacology

    Medical Education Cross-sectional questionnaire-based study Educational Study
    Objective
  57. 057

    Drug utilisation pattern and adherence to treatment guidelines in bronchial asthma and COPD patients at a respiratory medicine OPD

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  58. 058

    Drug utilisation and adverse drug reaction profile of biologic and targeted synthetic DMARDs in rheumatoid arthritis

    Drug Utilisation Prospective observational study Drug Utilisation Study
    Objective
  59. 059

    Comparative evaluation of topical NSAID formulations in osteoarthritis of the knee: efficacy, safety and cost

    Clinical Trials Randomised comparative trial Comparative Study
    Objective
  60. 060

    Evaluation of drug promotional literature received by physicians for compliance with WHO ethical criteria

    Rational Use & Behaviour Cross-sectional analytical study Cross-sectional Study
    Objective

MD Pharmacology thesis — frequently asked questions

How many MD Pharmacology thesis topics are listed here?

60+ MD Pharmacology thesis topics are listed on this page, organised by subsection of the Pharmacology curriculum. Click "Get Objective" on any title to receive the worked-out objective on WhatsApp instantly.

Do these Pharmacology topics include the objective and synopsis?

Yes — every title has a worked-out objective, synopsis structure, IEC-ready protocol, sample-size calculation and statistical plan. Click any title or "Get Objective" to receive the package on WhatsApp.

Are these topics suitable for DNB, MD and FCPS Pharmacology candidates?

Yes — these Pharmacology dissertation titles are aligned with NMC, NBE and DNB Pharmacology curricula and are suitable for MD Pharmacology, DNB Pharmacology and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Within minutes during business hours (08:00 – 21:00 IST) and within a few hours otherwise. Click "WhatsApp" on any title — our team responds 24×7.

WhatsApp